Indoco Remedies surges on commissioning new API manufacturing facility at Patalganga

29 Nov 2018 Evaluate

Indoco Remedies is currently trading at Rs. 223.00, up by 6.35 points or 2.93% from its previous closing of Rs. 216.65 on the BSE.

The scrip opened at Rs. 226.80 and has touched a high and low of Rs. 226.80 and Rs. 221.50 respectively. So far 129 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 317.00 on 24-Jan-2018 and a 52 week low of Rs. 150.25 on 08-Oct-2018.

Last one week high and low of the scrip stood at Rs. 238.00 and Rs. 203.00 respectively. The current market cap of the company is Rs. 1996.44 crore.

The promoters holding in the company stood at 58.87%, while Institutions and Non-Institutions held 14.97% and 26.16% respectively.

Indoco Remedies has commissioned a new state-of-the-art API manufacturing facility at Patalganga on November 27, 2018. This new cGMP compliant facility will enhance the existing manufacturing capacity from 150 tons to 600 tons p.a.

Major highlights of the facility include, solvent recovery system, automation, energy conservation and Zero Liquid Discharge Effluent Treatment facility. Emphasis on process safety and lant safety has been given by incorporating sophisticated safety devices.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

251.25 -0.65 (-0.26%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×